BPC-157 60mg — Vial Spec, Reconstitution Math & COA

BPC-157 60mg Vial Overview & High-Throughput Research Applications

A 60mg vial of BPC-157 contains 60 milligrams of high-purity, lyophilized Pentadecapeptide BPC-157 cake sealed under an inert nitrogen headspace. This expanded mass specification is designed for institutional laboratories, contract research organizations (CROs), and automated high-throughput screening platforms that demand large, consistent sample volumes from a single manufacturing lot.

In experimental settings, utilizing a high-mass vial eliminates lot-to-lot variance across extended longitudinal trials. Principal investigators select a 60mg specification when conducting large-cohort rodent studies, continuous cell culture line assays, or complex tissue engineering experiments that require standardized working solutions over several weeks or months. By preparing stock solutions from a unified fill, researchers ensure that target molar concentrations remain strictly controlled across every replicate.

PX1 Catalog Availability & Mass Format Options

PX1 Research currently supplies standard catalog sizes including the BPC-157 5mg and 10mg mass specifications. High-mass configurations such as the bpc-157 60mg yield are fulfilled as specialized custom preparations or high-volume institutional orders via our wholesale lab accounts program.

If your experimental protocol requires standard individual vials for acute trials or short-term pilot studies, researchers can explore our complete inventory of analytical-grade compounds across all peptides. Regardless of total mass, every vial originating from PX1 Research undergoes identical, rigorous quality control and analytical testing protocols.

Molecular Profile and Preclinical Mechanism of Action

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a sequence found in human gastric juice, represented by the primary amino acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val and a molecular weight of 1419.5 Da. As a primary tissue repair peptide, BPC-157 has been extensively evaluated in preclinical models for its role in modulating structural tissue integrity.

Preclinical studies suggest that BPC-157 accelerates the structural repair of tendon, ligament, skeletal muscle, and gut lining tissue. In vitro data indicate that these biological effects are mediated primarily through the stimulation of localized angiogenesis, upregulation of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), and activation of the focal adhesion kinase (FAK)-paxillin signaling pathway. These cascades promote accelerated endothelial cell migration, capillary tube formation, and collagen deposition at sites of cellular injury without exhibiting systemic hormonal activity.

Reconstitution Math and Concentration Calculations for 60mg

Reconstituting a bpc-157 60mg lyophilized cake requires precise volumetric planning to achieve desired working concentrations. Because 60mg represents a substantial mass of peptide, selecting the appropriate volume of diluent—such as sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile standard phosphate-buffered saline (PBS)—depends directly on the target microgram per microliter (µg/µL) concentration required for dosing equipment.

Below are standard laboratory calculations for reconstituting a 60mg vial across typical diluent volumes:

• 1.0 mL Diluent Yields: 60.0 mg/mL concentration (60.0 µg per 1 µL volumetric delivery). • 2.0 mL Diluent Yields: 30.0 mg/mL concentration (30.0 µg per 1 µL volumetric delivery). • 3.0 mL Diluent Yields: 20.0 mg/mL concentration (20.0 µg per 1 µL volumetric delivery). • 6.0 mL Diluent Yields: 10.0 mg/mL concentration (10.0 µg per 1 µL volumetric delivery).

When dissolving 60mg of peptide in smaller volumes (such as 1.0 mL), the resulting viscosity is significantly higher. Researchers utilizing automated pipetting systems or precise micro-fluidic channels typically prefer diluent volumes between 3.0 mL and 6.0 mL to reduce liquid retention in tips and maintain volumetric accuracy. To verify precise unit-to-volume conversions for custom protocol volumes, utilize our interactive laboratory reconstitution calculator.

Aliquot Planning and Freeze-Thaw Degradation Prevention

Once a bpc-157 60mg vial is reconstituted into liquid stock, exposing the solution to repeated freeze-thaw cycles introduces thermodynamic stress that can cleave peptide bonds and lead to progressive aggregation or loss of biological activity. Therefore, high-mass vials must be managed using strict aliquot protocols immediately following initial dissolution.

Under a sterile laminar flow hood, the freshly reconstituted 60mg stock should be sub-aliquoted into single-use, low-binding polypropylene micro-centrifuge tubes based on the daily volumetric consumption of the assay. Working aliquots designated for immediate use within 24–72 hours may be maintained at 2°C to 8°C. Long-term storage aliquots must be flash-frozen and preserved at -20°C or -80°C. Individual sub-aliquots should be thawed only once immediately prior to administration in cell culture assays or preclinical animal models.

Comparative Analysis: BPC-157 vs. TB-500 and GHK-Cu in Repair Assays

In musculoskeletal and cell migration research, BPC-157 is frequently studied alongside or compared against other prominent regenerative compounds. Understanding the mechanistic differences between these agents allows researchers to select the optimal peptide or combination for their specific experimental model.

While BPC-157 acts primarily through focal adhesion kinase pathways, VEGFR2 expression, and gastrointestinal endothelial repair (as detailed in our BPC-157 gut lining preclinical review), TB-500 (a synthetic fragment of Thymosin Beta-4) functions via actin sequestration and cell motility regulation across systemic tissues. Meanwhile, GHK-Cu operates through copper-chelated gene regulation, promoting collagen synthesis and extracellular matrix remodeling. In multi-arm preclinical trials, these compounds are often evaluated in parallel to isolate distinct pathways of soft tissue recovery. Broader investigative frameworks can be explored through the PX1 research library.

Analytical Verification & Lot-Matched Certificates of Analysis (COA)

Every batch of BPC-157 produced for PX1 Research is manufactured in USA-based, GMP-compliant facilities and subjected to rigorous independent testing in an ISO 17025 accredited laboratory. High-mass vials like the 60mg specification demand exact purity verification to ensure that high-density stock solutions do not concentrate trace synthesis impurities or residual solvents.

Quality assurance for each lot is established through two primary analytical methods: High-Performance Liquid Chromatography (HPLC) to confirm peptide purity (>98.0%), and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight (1419.5 Da). Additionally, every lot undergoes chromogenic Limulus Amebocyte Lysate (LAL) testing to enforce strict bacterial endotoxin limits (<0.01 EU/mg), ensuring compatibility with sensitive in vitro cell lines and in vivo animal models. Researchers can review and download lot-specific documentation directly from our COA portal.

Choosing Between 5mg, 10mg, and 60mg Mass Specifications

Selecting the correct vial size depends entirely on the design, duration, and subject count of the planned experimental protocol:

• 5mg & 10mg Vials: Best suited for short-term exploratory studies, low-throughput in vitro screens, or small animal cohorts. Lower mass specifications reduce compound waste if the reconstituted solution cannot be fully utilized within its stability window.

• 60mg Vials: Ideal for institutional research programs, continuous multi-week animal models, or automated robotic liquid handling systems. The primary advantage of the 60mg specification is lot uniformity—ensuring that hundreds of assay wells or experimental subjects are exposed to an identical peptide mass batch, eliminating inter-vial variance.

Laboratory Storage, Stability, and Handling Guidelines

To ensure compound stability and reproducible experimental outcomes, observe the following handling parameters for bpc-157 60mg specifications:

• Unreconstituted (Lyophilized) Powder: Store at -20°C in a dry, dark environment. Sealed lyophilized vials remain stable for up to 24 months from the date of manufacture. • Reconstitution Procedure: Allow the glass vial to reach room temperature before inserting the syringe needle. Introduce diluent slowly along the internal glass wall to prevent turbulent foaming. Gently swirl the vial until the cake is completely dissolved; never shake vigorously. • Reconstituted Solution: Liquid stock maintained at 2°C to 8°C must be used within 28 days. Frozen sub-aliquots stored at -20°C or -80°C remain stable for up to 6 months, provided freeze-thaw cycles are strictly avoided.